JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bryant, H. H.
Right arrow Articles by Krantz, J. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bryant, H. H.
Right arrow Articles by Krantz, J. C., Jr.
Journal of Pharmacology And Experimental Therapeutics, Vol. 121, Issue 2, 210-224, 1957
Copyright © 1957 by American Society for Pharmacology and Experimental Therapeutics


A PHARMACOLOGIC AND TOXICOLOGIC STUDY OF A NEW SERIES OF ANTISPASMODIC COMPOUNDS WITH SPECIAL REFERENCE TO STRUCTURE AND PHARMACOLOGIC ACTIVITY

Harold H. Bryant 1, Lloyd C. Felton 1, and John C. Krantz Jr. 1

1 Department of Pharmacology, University of Maryland School of Medicine and Hynson, Westcott & Dunning, Inc., Baltimore, Maryland

A new series of compounds which demonstrate a remarkable inhibitory effect upon gastrointestinal activity has been synthesized and studied. The compounds are ethers of dialkylethanolamines.

The inhibition of gastrointestinal action is not mediated through anticholinergic activity. Their apparent direct action upon the smooth muscle cells of the intestine would likely eliminate the untoward side effects so frequently attending the use of the anticholinergic drugs.

Certain members of the series exhibit an inhibitory effect upon gastric activity and do not affect intestinal motility.

These observations suggest the usefulness of selected members of this series of amino ethers in the treatment of hypermotility of the gastrointestinal tract.

Other pharmacologic activities not directly related to the gastrointestinal tract by certain members of the series have been noted. These are being evaluated and will be reported in subsequent publications.

Submitted on May 20, 1957







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1957 by the American Society for Pharmacology and Experimental Therapeutics.